Opus Genetics
Latest round
- Seed
Last raised
- Aug 2021
Total raised
- $9.5M
Investors
- 3
About Opus Genetics
Based in North Carolina, US, and founded in 2021, Opus Genetics, Inc. offers a gene therapy to treat rare retinal degenerative diseases. The company was co-founded by Jean Bennett and Ben Yerxa, two medical professionals. The company operates as a spin-out firm of Foundation Fighting Blindness, a venture arm of Retinal Degeneration Fund (RD Fund). In June 2023, Opus Genetics Inc., fully acquired Opus Genetics, Inc. from Bios Partners, Foundation Fighting Blindness, Retinal Degeneration Fund, and The Manning Family Foundation. The company has a series of research undergoing which focuses on two different diseases -- LCA (Leber congenital amaurosis) 5, an early-onset retinal degeneration, and BEST1, a biology and clinical research, and RDH12, a kind of early blindness. The preclinical programs under development are NMNAT1, which can modulate retinal NAD+, and RHO, which is a mutation-independent treatment of autosomal dominant RP (adRP) using a adRP-RHO canine model comparing AAV- and vehicle-treated retinas. Abovementioned are all wholly-owned pipelines of the company. The company’s lead programs are licensed from the University of Pennsylvania and will focus on treatments to address mutations in genes that cause different forms of LCA.
Who invested in Opus Genetics
3 investors across 1 round
See all investors in Opus Genetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 5, 2021
Amount
$9.5M
Investors
Questions about Opus Genetics
Who invested in Opus Genetics?
Opus Genetics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Opus Genetics raised?
Opus Genetics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Opus Genetics last raise money?
Opus Genetics's most recent round on record is a Seed, in Aug 2021.
What does Opus Genetics do?
Based in North Carolina, US, and founded in 2021, Opus Genetics, Inc.
Where is Opus Genetics headquartered?
Opus Genetics is headquartered in Farmington Hills, US.
Which VCs invest in companies like Opus Genetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Opus Genetics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Opus Genetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.